Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Filter by vocabulary: issues (multisite):

MSF denounces international inaction In Ebola-stricken African countries; states must deploy specialized medical assets now.

More >

 

MELBOURNE/NEW YORKHigh prices continue to represent a major barrier to affordable access of both new HIV medicines and viral load testing—which is the best way to monitor whether treatment is working—according to two reports released today by international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF). 

More >

 

NEW YORK/BRUSSELS—Bringing the spreading Ebola epidemic under control in West Africa will require a massive deployment of resources by regional governments and aid agencies, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today, warning that it has reached the limit of what it can do to fight the deadly outbreak.

More >

Scores of civilians have been killed, displaced, and cut off from medical care by organized violence in the Ouaka region of the Central African Republic.

More >

Antoine Foucher, MSF’s head of mission in Ethiopia, describes the multi-layered emergency facing South Sudanese refugees in the country.

More >

MSF and WHO Study Shows Rapid Diagnosis Now Feasible Without a Lab

More >

Use of vaccine in Guinea demonstrates it can be used to help control and prevent deadly outbreaks.

More >

Phumeza Tisile, co-author of the DR-TB Manifesto and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide.

More >

 

Geneva/New York—Patent barriers and high prices on oral treatments for hepatitis C could make it too expensive for developing countries to scale-up diagnosis and treatment of the disease, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today. The warning comes as the World Health Organization (WHO) issued the first-ever guidelines for treatment of hepatitis C virus (HCV). 

More >

GENEVA/LONDON—With patent barriers on new oral drugs to treat hepatitis C in developing countries, the high price of new treatment could squander the opportunity governments now have to scale up diagnosis and treatment for the disease, international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) warned today. The caution comes as MSF welcomed the first-ever World Health Organization (WHO) guidelines for hepatitis C virus (HCV).  

More >

Pages